Pharmaco - Press Releases

Date	Title	Company
19-Aug-2021	OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices	OncoHost
19-Aug-2021	Statement on Boosting with the Johnson & Johnson COVID-19 Vaccine	Johnson & Johnson
19-Aug-2021	AbbVie Kicks Off Two-Week Public Voting Open for the 2021 AbbVie CF Scholarship Thriving Student Awards	AbbVie
19-Aug-2021	Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19	RELIEF THERAPEUTICS Holdings AG
18-Aug-2021	Aptar Pharma Granted Exclusive License Option by Pharmaxis to Develop and Promote High Payload Dry Powder Inhaler	Aptar Pharma
18-Aug-2021	Oxurion NV - Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science, the American Academy of Ophthalmology Journal	Oxurion NV
18-Aug-2021	PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments	PureTech
18-Aug-2021	Medidata Announces Significant Enhancement to myMedidata Suite of Decentralized Clinical Trials (DCTs) Capabilities with Introduction of Video eConsent	Medidata
18-Aug-2021	Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreement	Orion Corporation
18-Aug-2021	Real-world data shows one shot Sputnik Light vaccine (the first component of the Sputnik V vaccine) has high safety and 93.5% efficacy against COVID during vaccination in Paraguay	Russian Direct Investment Fund
18-Aug-2021	Thermo Fisher Scientific Named IndustryWeek Best Plants Award Winner 2021	Thermo Fisher Scientific
18-Aug-2021	Release of results for the third quarter 2020/21 (ending 30 June 2021) on 25 August 2021	Douglas GmbH
18-Aug-2021	DEFENCE THERAPEUTICS SELECTS THE BEST 8 ACCUM(TM) VARIANTS TO OPTIMIZE ITS ADC THERAPEUTIC	Defence Therapeutics Inc.
18-Aug-2021	Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent	Zur Rose Group AG
17-Aug-2021	Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance	Epigenomics AG
17-Aug-2021	Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis	Mundipharma
17-Aug-2021	Abivax receives approval for ABX464 phase 1 study in Japanese subjects for subsequent inclusion of Japan into the global phase 3 program in ulcerative colitis	ABIVAX
17-Aug-2021	Second-generation mRNA-based COVID-19 vaccine candidate, CV2CoV, shows improved immune response and protective effect in preclinical study	CureVac
17-Aug-2021	FDA Grants Emergency Use Authorization for Two Next-Generation COVID-19 Assays from Thermo Fisher Scientific	Thermo Fisher Scientific
17-Aug-2021	Anticancer Agent "Tazverik® Tablets 200mg" (Tazemetostat Hydrobromide) Launched In Japan For EZH2 Gene Mutation-Positive Follicular Lymphoma	Eisai